DOCSLIB.ORG

AWARDS There Are Several Awards Given by the Society. the Walter Reed Medal, the Ben Kean Medal and the Joseph Augustin Leprince

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
AWARDS There Are Several Awards Given by the Society. the Walter Reed Medal, the Ben Kean Medal and the Joseph Augustin Leprince MEMBERSHIP DIRECTORY 127 AWARDS There are several awards given by the Society. The Walter Reed Medal, the Ben Kean Medal and the Joseph Augustin LePrince Medal are given sequentially every third year, whereas the Bailey K. Ashford Medal is given annually. The Donald Mackay Medal is given annually with recipients chosen in alternating years by the American Society of Tropical Medicine and Hygiene and the Royal Society of Tropical Medicine and Hygiene. These awards, as well as Certificates of Recognition, are selected by a committee composed of the immediate three past presidents of the Society. Nominations for these awards may be submitted by any member and should briefly summarize the candidate’s qualifications and accomplishments. Young Investigator Awards are selected based on presentations made at the annual scientific meeting of the Society. JOSEPH AUGUSTIN LePRINCE MEDAL—In recognition of outstanding work in the field of malariology. Wilbur Milhous ...........................................................................2009 Thomas E. Wellems ...................................................................2006 Stephen L. Hoffman ...................................................................2006 Craig Canfield ............................................................................2003 Louis Miller ................................................................................2000 Ruth Nussenzweig.....................................................................1997 Wallace Peters ...........................................................................1994 P.C.C. Garnham .........................................................................1991 William Trager ............................................................................1991 David F. Clyde ............................................................................1988 William E. Collins .......................................................................1985 Leon H. Schmidt ........................................................................1982 Paul F. Russell ...........................................................................1979 Martin D. Young ..........................................................................1976 Clay G. Huff ...............................................................................1973 R. Robert Coatney .....................................................................1970 Arnoldo Gabaldon .....................................................................1967 Don E. Eyles ..............................................................................1964 Justin Andrews ..........................................................................1960 Louis L. Williams, Jr. ..................................................................1957 Brian Maegraith .........................................................................1954 Joseph Augustin LePrince .........................................................1951 BAILEY K. ASHFORD MEDAL—For distinguished work in tropical medicine. Customarily, it is given to an individual in mid-career (within twenty years of PhD or MD). Louise Ivers ...............................................................................2011 Chandy John .............................................................................2011 Joseph Vinetz ............................................................................2011 Eric Houpt ..................................................................................2010 Carolina Barillas-Mury ...............................................................2010 Jesus Valenzuela .......................................................................2009 Kevin Kain..................................................................................2008 Michael Cappello .......................................................................2007 Jeremy Farrar ............................................................................2006 Thomas A. Wynn .......................................................................2006 Mary E. Wilson...........................................................................2005 Frank O. Richards ......................................................................2005 J. Kevin Baird .............................................................................2005 Xinzhuan Su ..............................................................................2004 Amy Klion ..................................................................................2004 Peter Hotez ................................................................................2003 Christopher Plowe .....................................................................2002 Edward J. Pearce .......................................................................2002 Philip Scott ................................................................................2001 David Sacks ...............................................................................2001 128 AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE Barbara Mann .......................................................2001 Alan F. Sher ..........................................................1989 Terrie Taylor ..........................................................2000 Eric A. Ottesen......................................................1989 Thomas Nutman ...................................................2000 Daniel G. Colley ....................................................1989 W. Ripley Ballou ....................................................2000 George V. Hillyer ...................................................1986 Jose Ribeiro ..........................................................1999 Adel Mahmoud .....................................................1983 Barbara L. Herwaldt ..............................................1999 Joel M. Dalrymple .................................................1983 Ayoade M. Oduola ................................................1998 Myron G. Schultz ..................................................1980 Donald A. Harn .....................................................1998 James L. Hardy .....................................................1977 James W. Kazura ..................................................1997 Kenneth S. Warren ................................................1974 Stephanie James ..................................................1996 Robert E. Shope ...................................................1974 Dyann F. Wirth ......................................................1995 Karl M. Johnson ....................................................1971 Thomas E. Wellems ..............................................1995 Leon Rosen ..........................................................1968 Jonathan I. Ravdin ................................................1994 Franklin A. Neva ....................................................1965 Wilbur K. Milhous ..................................................1993 Eli Chernin ............................................................1961 Richard M. Locksley..............................................1993 Geoffrey M. Jeffery ...............................................1959 Kamini Mendis ......................................................1993 Paul P. Weinstein ..................................................1957 Nancy G. Saravia ..................................................1993 Joseph Greenberg ................................................1954 Diane McMahon-Pratt ...........................................1992 Leo J. Jachowski, Jr. ............................................1952 Charles H. Hoke, Jr. .............................................1992 Robert J. Huebner ................................................1949 Stephen L. Hoffman ..............................................1992 Jose Oliver-Gonzalez ...........................................1947 Richard Yanagihara ...............................................1991 James Watt ...........................................................1945 Peter F. Weller .......................................................1991 Norman E. Topping ...............................................1943 Donald S. Burke ....................................................1990 Lloyd E. Rozeboom...............................................1941 WALTER REED MEDAL—To recognize distinguished accomplishment in the field of tropical medicine. Louis Miller ................................................................................2011 Richard L. Guerrant ...................................................................2008 Karl M. Johnson ........................................................................2005 Thomas Monath ........................................................................2002 Philip K. Russell ........................................................................1999 Thomas H. Weller ......................................................................1996 Robert E. Shope ........................................................................1993 George B. Craig, Jr. ..................................................................1993 Donald A. Henderson ................................................................1993 Willy Burgdorfer .........................................................................1990 Paul C. Beaver ...........................................................................1990 William C. Reeves .....................................................................1987
Load more

Recommended publications
  • Jeremy Farrar
    FEATURE The BMJ THE BMJ INTERVIEW BMJ: first published as 10.1136/bmj.n459 on 19 February 2021. Downloaded from [email protected] Cite this as: BMJ 2021;372:n459 http://dx.doi.org/10.1136/bmj.n459 Jeremy Farrar: Make vaccine available to other countries as soon as Published: 19 February 2021 our most vulnerable people have received it The SAGE adviser and Wellcome Trust director tells Mun-Keat Looi how the UK government acted too slowly against the pandemic, about the perils of vaccine nationalism, and why he is bullish about controlling covid variants Mun-Keat Looi international features editor “Once the UK has vaccinated our most vulnerable among healthcare workers. We had no human communities and healthcare workers we should make immunity, no diagnostics, no treatment, and no vaccines available to other countries,” insists the vaccines. infectious disease expert Jeremy Farrar. This could Every country should have acted then. Singapore, avert further public health and economic disaster, China, and South Korea did. Yet most of Europe and he says, describing it as “enlightened self-interest, North America waited until the middle of March, and as well as the right ethical thing to do.” that defined the first wave. Countries including the In April 2020, soon after the first UK lockdown began, UK were unwilling to act early, before they felt Farrar predicted that the UK would have one of the comfortable; were unwilling to go deeper than they worst covid-19 death rates in Europe. As a member thought they had to; and were unwilling to keep of the Scientific Advisory Group for Emergencies restrictions in place for as long as was needed.
    [Show full text]
  • (ITFDE) October 22, 2019
    Summary of the Thirtieth Meeting of the International Task Force for Disease Eradication (ITFDE) October 22, 2019 The 30th Meeting of the International Task Force for Disease Eradication (ITFDE) was convened at The Carter Center in Atlanta, GA, USA from 8:30 am to 5:00 pm on October 22, 2019 to discuss the potential for eradication of measles and rubella. The Task Force members are Dr. Stephen Blount, The Carter Center (Chair); Dr. Peter Figueroa, The University of the West Indies, Jamaica; Dr. Donald Hopkins, The Carter Center; Dr. Fernando Lavadenz, The World Bank; Dr. Mwelecele Malecela, World Health Organization (WHO); Professor David Molyneux, Liverpool School of Tropical Medicine; Dr. Ana Morice, Independent Consultant; Dr. Stefan Peterson, UNICEF; Dr. David Ross, The Task Force for Global Health; Dr. William Schluter, Centers for Disease Control and Prevention (CDC); Dr. Nilanthi de Silva, University of Kelaniya, Sri Lanka/WHO Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTDs); Dr. Dean Sienko, The Carter Center; Dr. Laurence Slutsker, PATH; Dr. Jordan Tappero, Bill & Melinda Gates Foundation; Dr. Ricardo Thompson, National Institute of Health (Mozambique); and Dr. Dyann Wirth, Harvard School of Public Health. Eleven Task Force members (Blount, Figueroa, Hopkins, Morice, Ross, Sienko, de Silva, Slutsker, Tappero, Thompson, Wirth) participated in this meeting; three were represented by an alternate (Drs. Fatima Barry for Lavadenz, Steve Cochi for Schluter, Yodit Sahlemariam for Peterson). Presenters included Drs. Sunil Bahl, WHO/SEARO; Amanda Cohn, CDC; Matthew Hanson, Bill & Melinda Gates Foundation; Alan Hinman, The Task Force for Global Health; Mark Jit, London School of Tropical Medicine & Hygiene; Ann Lindstrand, WHO/Geneva; Balcha Masresha, WHO/AFRO; Patrick O’Connor, WHO/Europe; and Desiree Pastor, Pan American Health Organization (WHO/PAHO).
    [Show full text]
  • Financing Vaccines for Global Health Security
    NBER WORKING PAPER SERIES FINANCING VACCINES FOR GLOBAL HEALTH SECURITY Jonathan T. Vu Benjamin K. Kaplan Shomesh Chaudhuri Monique K. Mansoura Andrew W. Lo Working Paper 27212 http://www.nber.org/papers/w27212 NATIONAL BUREAU OF ECONOMIC RESEARCH 1050 Massachusetts Avenue Cambridge, MA 02138 May 2020 We thank Ellen Carlin, Doug Criscitello, Margaret Crotty, Narges Dorratoltaj, Per Etholm, Jeremy Farrar, Nimah Farzan, Mark Feinberg, Jose-Maria Fernandez, John Grabenstein, Peter Hale, Richard Hatchett, Peter Hotez, Daniel Kaniewski, Adel Mahmoud, Mike Osterholm, May 2020 Farrar, Nimah Kevin Outterson, Chi Heem Wong, CEPI leadership, and two reviewers and the editor for helpful comments and discussion, and Jayna Cummings for editorial assistance. Research support from the MIT Laboratory for Financial Engineering and the Warren Alpert Medical School of Brown University is gratefully acknowledged. The views and opinions expressed in this article are those of the authors only, and do not necessarily represent the views and opinions of any institution or agency, any of their affiliates or employees, any of the individuals acknowledged above, or the National Bureau of Economic Research. Funding support from the MIT Laboratory for Financial Engineering is gratefully acknowledged, but no direct funding was received for this study and no funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of this manuscript. The authors were personally salaried by their institutions during the period of writing (though no specific salary was set aside or given for the writing of this manuscript). At least one co-author has disclosed a financial relationship of potential relevance for this research.
    [Show full text]
  • Oxford Medicine
    Oxford Medicine THE NEWSLETTER OF THE OXFORD MEDICAL ALUMNI OXFORD MEDICINE • DECEMBER 2019 Courtesy of Ludwig Cancer Research of Ludwig Cancer Courtesy The Regius Professor Sir Tingewick is Does reflects on Peter Ratcliffe 80! Developmental 45 years in FRS, Nobel Dyslexia Really medicine Laureate Exist? 2 / OXFORD MEDICINE DECEMBER 2019 President’s Piece Welcome to the December Sir William Osler’s Centenary commemorations will issue of Oxford Medicine, the continue throughout the year in Oxford and beyond. newsletter for Oxford Medical The Osler Club is the first of a number of thriving Alumni (OMA) who have postgraduate Oxford medical societies we plan to feature. trained, taught, or worked at Professor Terence Ryan summarises this year’s five Osler Oxford. Professor John Morris, Club seminars exploring the Oslerian theme ‘For Health OMA president for the past and Wellbeing, Science and Humanities are one’. six years, handed the baton Tingewick is 80 this year. In 2019, as in 1939, Tingewick to me in September. It is a Dr Lyn Williamson, is still the most inclusive Oxford clinical student society. OMA President daunting task to take over from This year, every first year clinical student took part - someone so beloved and so that is 165! The show was a triumph of teamwork and respected, who has taught anatomy to generations talent. The legacy of camaraderie will last a lifetime - as of Oxford students and postgraduates, and shaped witnessed by the 80th anniversary celebrations. Dr Derek the preclinical school for many years. With his Roskell, Senior Tingewick Member for 25 years adds his characteristic kindness and wisdom, he said: ‘You will be fine - and I will be there to advise you’.
    [Show full text]
  • Trustees' Annual Report and Financial Statements 31 March 2016
    THE FRANCIS CRICK INSTITUTE LIMITED A COMPANY LIMITED BY SHARES TRUSTEES’ ANNUAL REPORT AND FINANCIAL STATEMENTS 31 MARCH 2016 Charity registration number: 1140062 Company registration number: 6885462 The Francis Crick Institute Accounts 2016 CONTENTS INSIDE THIS REPORT Trustees’ report (incorporating the Strategic report and Directors’ report) 1 Independent auditor’s report 12 Consolidated statement of financial activities 13 Balance sheets 14 Cash flow statements 15 Notes to the financial statements 16 1 TRUSTEES’ REPORT (INCORPORATING THE STRATEGIC REPORT AND DIRECTORS’ REPORT) The trustees present their annual directors’ report together with the consolidated financial statements for the charity and its subsidiary (together, ‘the Group’) for the year ended 31 March 2016, which are prepared to meet the requirements for a directors’ report and financial statements for Companies Act purposes. The financial statements comply with the Charities Act 2011, the Companies Act 2006, and the Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK (FRS102) effective 1 January 2015 (Charity SORP). The trustees’ report includes the additional content required of larger charities. REFERENCE AND ADMINISTRATIVE DETAILS The Francis Crick Institute Limited (‘the charity’, ‘the Institute’ or ‘the Crick) is registered with the Charity Commission, charity number 1140062. The charity has operated and continues to operate under the name of the Francis Crick
    [Show full text]
  • COVID-19 Vaccine Development, Strategy and Implementation
    Symposium: Vaccines and Global Health: COVID-19 Vaccine Development, Strategy and Implementation The Program in Vaccine Education at the Columbia University Vagelos College of Physicians & Surgeons’ mission is to educate medical students and to inform health care professionals, public health experts, academic, government and industry researchers, policy makers, global health non-governmental organizations, journalists, and the general public as to the cutting-edge advances and challenges in modern vaccine development. The Columbia University convenors are Drs. Lawrence Stanberry (Co-Director, PVE), Philip LaRussa (Co-Director, PVE), Wilmot James (Associate Director, PVE), and Marc Grodman (Special Advisor, PVE). We have put together a group of 25 outstanding speakers who have been intimately involved with all aspects of COVID-19 vaccine development, strategy, and implementation. We are delighted to present this five-day virtual symposium at the cusp of the world’s transition to controlling the COVID-19 pandemic. Monday, February 22 National, Regional and Global Response to an Unprecedented Challenge 12:00-12:10 Welcome: Lee Bollinger, JD – President, Columbia University 12:10-12:15 Moderator: Lawrence R. Stanberry, MD, PhD – Director of the Programs in Global Health, Columbia University Vagelos College of Physicians and Surgeons 12:15-12:45 Keynote: Sir Jeremy Farrar, BSc, MBBS, PhD – Director, Wellcome Trust The Role of the Wellcome Trust in COVID-19 Vaccine Preparedness 12:45-1:30 Speakers: - Shabir Madhi, MBChB, MMed, FCPaeds PhD – Professor of Vaccinology, University of the Witwatersrand – A South African perspective on vaccine preparedness and availability. - Nancy Messonnier, MD – Director, National Center for Immunization and Respiratory Diseases, US CDC – A US CDC perspective on vaccine preparedness and availability.
    [Show full text]
  • Meeting Schedule/Structure
    Special isirv-AVG Virtual Conference on ‘Therapeutics for COVID-19’ Tuesday 6th - Thursday 8th October 2020 (12.00-16.00 GMT daily) Programme Tuesday 6 October 12:00-12:15 Welcome Alan Hay, Francis Crick Institute, London, UK & Frederick Hayden, University of Virginia School of Medicine, Charlottesville, VA, USA Introduction Jeremy Farrar, Wellcome Trust, London, UK Chairs TBC 12:15-12:40 COVID-19 Clinical Spectrum, Complications, and Coinfections Bin Cao, China-Japan Friendship Hospital, Beijing, China 12:40-13:00 COVID-19 Viral Replication Kinetics Malik Peiris, University of Hong Kong, HK SAR, China 13:00-13:20 COVID-19 Autopsy Findings Xiuwu Bian, China (TBC) 13:20-13:40 Immunopathogenesis of COVID-19 Peter Openshaw, Imperial College London, UK 13:40-14:00 Pathogenesis and Management of ARDS – Richard Wunderink, Northwestern University, Evanston, IL, USA 14:00-14:10 Comfort Break 14:10-15:10 Chairs TBC Oral Abstract Session 1 4 x 15 minute presentations (including Q&A) 15:10-15:20 Close of Day 1 Poster Viewing Page 1 of 3 Wednesday 7 October Chairs TBC 12:00-12:20 SARS-CoV-2 Antiviral Targets Mark Denison (accepted in principle) 12:20-12:40 Pre-clinical Models for Downselecting Candidates Andres Pizzorno, International Center for Research in Infectious Diseases, Lyon, France 12:40-13:10 RECOVERY Trial and Strategies for Rapid Clinical Testing Peter Horby, Oxford, UK 13:10-13:30 Convalescent Plasma and Polyclonal Antibodies - Michael Joyner, Mayo Clinic, MN, USA 13:30-13:50 Monoclonal Antibodies Erica Saphire, La Jolla Institute for
    [Show full text]
  • World Economic Forum Annual Meeting 2017 Programme
    Global Agenda World Economic Forum Annual Meeting 2017 Programme Davos-Klosters, Switzerland 17-20 January Programme Pillars Programme Icons Programme Co- Chairs Experience Webcast Session Frans van Houten, President and Chief Executive Officer, Royal Philips, Netherlands Immersive experiences across time, space and emotions made memorable by Interpretation Brian T. Moynihan, Chairman of the inspiring interactions and thought- Board and Chief Executive Officer, provoking settings On the record Bank of America Corporation, USA Sharmeen Obaid-Chinoy, Discover Sign-up required Documentary Filmmaker, SOC Films, Pakistan; Young Global Leader Engaging explorations of the conceptual breakthroughs of our time and their Helle Thorning-Schmidt, Chief transformative impact on society, industry Executive Officer, Save the Children and policy International, United Kingdom Meg Whitman, President and Chief Debate Executive Officer, Hewlett Packard Enterprise, USA Insightful exchanges bringing together diverse opinions and ideas on today's most relevant economic, scientific and political issues Collaborate Hands-on sessions where leaders from all backgrounds come together to shape solutions to the world's most pressing challenges World Economic Forum Annual Meeting 2017 - Programme 2 Sunday 15 January 06.00 - 01.00 Registration - Mühlestrasse 6 - 7260 Davos Dorf 1 registration Registration Opens Pick up your badge as of Sunday 15 January at 06.00 at Registration located at Mühlestrasse 6. Please note that the Congress Centre opens on Monday 16 January
    [Show full text]
  • Research Bodies Vow to Share Data on Zika
    BMJ 2016;352:i877 doi: 10.1136/bmj.i877 (Published 11 February 2016) Page 1 of 1 News BMJ: first published as 10.1136/bmj.i877 on 11 February 2016. Downloaded from NEWS Research bodies vow to share data on Zika Zosia Kmietowicz The BMJ Academic journals, charities, research funders, and institutes available to all, free of charge, as soon as is feasibly possible. have committed themselves to sharing data and results relevant Journal signatories have said that doing this would not preclude to the current Zika virus outbreak and future public health researchers from subsequently publishing papers in their titles. emergencies as rapidly and openly as possible. Jeremy Farrar, director of the Wellcome Trust and a signatory The organisations, including the Bill and Melinda Gates to the statement, said, “Research is an essential part of the Foundation, Médecins Sans Frontières, the US National response to any global health emergency. This is particularly Institutes of Health, and the UK health research charity the true for Zika, where so much is still unknown about the virus, Wellcome Trust, along with leading academic journals such as how it is spread, and the possible link with microcephaly. The BMJ, Nature, Science, and the New England Journal of “It’s critical that as results become available they are shared Medicine, have signed a joint declaration and hope that other rapidly in a way that is equitable, ethical, and transparent. This bodies will add their names to the statement in the coming will ensure that the knowledge gained is turned quickly into weeks. health interventions that can have an impact on the epidemic.” The statement is intended to ensure that any information that http://www.bmj.com/ might have value in combating the Zika outbreak is made on 27 September 2021 by guest.
    [Show full text]
  • Religious Conviction and the Boston Inoculation Controversy of 1721
    W&M ScholarWorks Undergraduate Honors Theses Theses, Dissertations, & Master Projects 5-2011 Religious Conviction and The Boston Inoculation Controversy of 1721 Anna E. Storm College of William and Mary Follow this and additional works at: https://scholarworks.wm.edu/honorstheses Part of the History Commons Recommended Citation Storm, Anna E., "Religious Conviction and The Boston Inoculation Controversy of 1721" (2011). Undergraduate Honors Theses. Paper 400. https://scholarworks.wm.edu/honorstheses/400 This Honors Thesis is brought to you for free and open access by the Theses, Dissertations, & Master Projects at W&M ScholarWorks. It has been accepted for inclusion in Undergraduate Honors Theses by an authorized administrator of W&M ScholarWorks. For more information, please contact [email protected]. Religious Conviction and The Boston Inoculation Controversy of 1721 A thesis submitted in partial fulfillment of the requirement for the degree of Bachelors of Arts in History from The College of William and Mary Anna Storm Accepted for _________________________________ (Honors, High Honors, Highest Honors) __________________________ Paul Mapp, Director __________________________ Chandos Brown __________________________ Randolph Coleman Williamsburg, VA April 25, 2011 2 Introduction “Ultimately, society must recognize that science is not a democracy in which the side with the most votes or the loudest voices gets to decide what is right.”1 This quote is part of a larger article, “The Age-Old Struggle against the Antivaccinationists,” published on January 13, 2011 in the New England Journal of Medicine. Written by Gregory A Poland, M.D., and Robert M. Jacobson, M.D., the article discusses the problem of “antivaccinationists,” or people who use fear to deter society from vaccinating themselves and their families.
    [Show full text]
  • Guinea Worm Wrap-Up #262
    Public Health Service DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Disease Control And Prevention (CDC) Memorandum Date: August 8, 2019 From: WHO Collaborating Center for Dracunculiasis Eradication, CDC Subject: GUINEA WORM WRAP-UP #262 To: Addressees “The public interest requires doing today those things that men of intelligent good will would wish, five or ten years hence, had been done.” Edmund Burke ABDULRAHMAN AL-AWADI (1936-2019), ICCDE CHAIRMAN It is with deep sadness and painful regret that we report the recent passing of Dr. Abdulrahman A. Al- Awadi on July 6, 2019. As President of the Thirty-third World Health Assembly, Dr. Al-Awadi signed the declaration of global eradication of smallpox with World Health Organization Director-General Dr. Halfdan Mahler on May 8, 1980. When the World Health Organization (WHO) established the independent International Commission for the Certification of Dracunculiasis Eradication (ICCDE) in 1995 he was elected chairman of the Commission. After studies in his native Kuwait, Dr. Al-Awadi received his advanced education at the American University of Beirut (B.S., 1958) in Lebanon, the University of Aberdeen (M.D., 1963) in Scotland and Harvard University (M.P.H., 1965) in the United States. According to the Kuwait Times, he joined Kuwait’s Ministry of Health in 1963, was elected to the National Assembly in 1975, and served as Minister of Public Health (1975-1983), Minister of Public Health and Minister of Planning (1983- 1986), Minister of Planning (1988-1990), and Minister of State for Cabinet Affairs (1990-1991). As Minister of Public Health, he led a “comprehensive health renaissance where most hospitals were built and the medical mission for Hajj was developed”.
    [Show full text]
  • Drug Development for Neglected Tropical Diseases: Dndi and the Product Development Partnership (PDP) Model
    Drug Development for Neglected Tropical Diseases: DNDi and the Product Development Partnership (PDP) Model Julia Tuttle A thesis submitted to the Department of Global Health for honors Duke University Durham, North Carolina 2016 Drug Development for Neglected Tropical Diseases Julia Tuttle Table of Contents Abstract 3 Introduction 1. Background 1.1 Economics of Drug Development 1.2 NTDs: The remaining market failure 2. Exploring Solutions 2.1 Theories of Alternative Policy Action 2.2 Public-Private Partnerships 3. Case Study: DNDi 3.1 Organizational Overview 3.2 Therapeutic Advancements 3.3 Pipeline Progress 3.4 Current Operations 3.4.1 Target Product Profiles 3.4.2 Clinical Trial Platforms 3.4.3 Developing Drug Screens 3.4.4 Drug Discovery 3.4.5 Demonstration Project 3.4.6 Advocacy 4. Conclusion 4.1 Summary of DNDi 4.2 Analysis of Strengths Independence Health Systems Strengthening and Technical Capacity Technology Transfer Openness and Access Breadth of Impact Strong Partnerships Cost-efficiency 4.3 Analysis of Weaknesses Financial Limitations Political Context New Obstacles Moving Forward 4.4 Final Remarks Appendix 1- Chart of Product Development Partnerships (PDPs) Appendix 2- DNDi Organizational Overview Appendix 3- DNDi Demonstration Project Graphic Overview Appendix 4- List of DNDi Partners and Funders 2 Drug Development for Neglected Tropical Diseases Julia Tuttle Abstract Neglected tropical diseases (NTDs), including leishmaniasis, Chagas disease, sleeping sickness, dengue fever, and schistosomiasis to name a few, are endemic in 149 countries and impact 1.4 billion people- often the most vulnerable groups in the poorest countries (WHO 2016). Unfortunately, many of these diseases have no vaccines to prevent them, nonexistent or incredibly problematic treatments, and limited resources dedicated to monitoring, controlling, and improving the situation of those who are infected.
    [Show full text]